Press Releases

CluePoints Covid-19 Support Benefits Over 200 Clinical Studies Directly Affected by the Pandemic

CluePoints, the premier provider of Risk-Based Quality Management (RBQM) and Data Quality Oversight Software for clinical trials, today announced that its recently launched complimentary COVID-19 risk assessment package and Data Surveillance solution is being utilized in over 200 ongoing studies that are directly affected by Covid-19.

Lubrizol Contributes to Nike’s Efforts to Make Full-Face Shields for Frontline Medical Workers

BioIVT Introduces High-purity Kupffer Cells to Support Drug Discovery and Development for Liver Diseases and Help Predict Adverse Drug Reactions

Dysregulation of the Kupffer cell response contributes to liver diseases such as nonalcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), and liver fibrosis.

Rho Recognized with CRO Leadership Award from Leading Industry Publications

Rho Recognized with CRO Leadership Award from Leading Industry Publications Research Triangle Park, NC – May 11, 2020 – Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, has been honored with a 2020 CRO Leadership Award by leading industry publications Life Science Leader and Clinical Leader for the third time. The company was recognized in multiple categories, including Compatibility (Overall, Small Pharma); Expertise (Small Pharma); Quality (Overall, Small Pharma); and Reliability (Overall, Small Pharma). Selected by key decision makers in pharmaceutical and biopharmaceutical companies, award recipients are recognized as top CROs in the industry based on their recent achievements and ability to exceed customer expectations.

Two Top 25 Global Pharma Companies Adopt LifeSphere® Intake and Triage to Automate Adverse Event Case Processing

ArisGlobal Introduces LifeSphere CTMS10, Bringing Modern Simplicity and Efficiency to Clinical Trial Management

ArisGlobal, the leading provider of software that automates core drug development functions for over 300 life sciences companies, today announced the release of LifeSphere® CTMS10, a modern, end-to-end solution that makes the entire clinical trial management process easier and more transparent for companies of all sizes. Learn more...

India’s Largest Biopharmaceutical Selects LifeSphere® eTMF to Streamline Clinical Trial Document Management

ArisGlobal, the leading provider of life sciences software that automates drug development functions for over 300 life sciences companies, today announced that the largest biopharmaceutical company in India, a globally recognized organization enabling access to high quality, advanced therapies for chronic diseases, has selected ArisGlobal’s LifeSphere® eTMF as its electronic trial master file system.

COUCH Health demands the clinical research industry improves diversity once and for all

As advocates of diverse and inclusive clinical trials, patient engagement agency COUCH Health is calling on the industry take action to make clinical research more inclusive and representative of all populations. Demand Diversity has launched with the aim to raise awareness of the lack of diversity in clinical research, and make change happen.

Luye Pharma Group Selects LifeSphere Signal and Risk Management to Automate Drug Safety Signal Detection

ArisGlobal, the leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, today announced Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing, and sale of innovative medications, (02186.HK) has selected LifeSphere® Signal and Risk Management as its next-generation signal detection tool. Learn more...

Imvax Appoints Mark Exley, Ph.D. as Chief Scientific Officer

Imvax, Inc., a clinical-stage biotechnology company, today announced that Mark Exley, PhD, has been appointed as Chief Scientific Officer (CSO). Reporting to Imvax Chief Executive Officer (CEO) John Furey, Dr. Exley joins the company as it is developing Imvax’s lead product candidate, IGV-001, for the treatment of newly diagnosed glioblastoma multiforme (GBM).

EPS Corporation Signs Groundbreaking Agreement to Drive Increased Quality and Safety Using CluePoints Risk-Based Quality Management Solution

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software for clinical trials, today announced that EPS, a Tokyo based CRO, have entered into an agreement with CluePoints to offer Risk Based Quality Management (RBQM) solutions to its sponsors to drive early risk detection, improve quality and enhance patient safety in a cost-effective and resource-efficient manner.

Elsevier’s PharmaPendium and ExactCure reviewing 20 approved drugs for COVID-19 therapies

AI powered ‘digital twins’, using PharmaPendium data, will help physicians improve dosing of COVID-19 therapies with personalized model simulations

TailorMed launches Remote Navigation solution to enable hospital staff to help their patients from afar and ensure that healthcare providers can recover lost revenues

TailorMed today launched the Remote Navigation solution as part of its unique and industry-leading financial navigation solution. It is the first of its kind to enable healthcare providers and their staff to remotely work with patients to ease the patient's and hospital's financial burden. The new product also helps healthcare providers quickly access TailorMed's much larger suite of financial navigation technology and services currently available to TailorMed's 50 client hospitals and medical practices.

SGS Digicomply Launches AI System to Find Answers on COVID-19 within Research Articles

SGS Digicomply has announced the launch of a new version of its software dedicated exclusively to the research community and focused on finding ways to respond to the COVID-19 pandemic.

Independent SMO Panthera Biopartners continues to expand its network of clinical trial sites

Panthera opens for clinical trials in Manchester, its second clinical trial site in the UK, with additional health and safety precautions to protect staff and patients from COVID-19.

Liberty16 being paired with Oxford Nanopore Flongle

ERT Delivers Actionable Insights to Identify COVID-related Clinical Trial Risks

Intuitive COVID-19 Dashboard highlights patient compliance risks to protect study outcomes

TraceLink Announces New Agile Solutions to Accelerate Digital Supply Chain Transformation; Allocates $1 Million Charitable Donation for COVID-19 Relief

Tufts CSDD-eClinical Solutions Clinical Data Study Shows 32 Percent Increase in Trial Cycle Time Metric

Robust data strategy and improved technology infrastructure to accelerate drug development

ERT Offers First Patient-Administered ECG Assessment for Continuation of Clinical Trials during COVID-19

Patients monitor cardiac safety at home with easy-to-use, FDA-cleared KardiaMobile 6L personal ECG